SCHEMBL6005346

SCHEMBL6005346

O=C(O)C(Cc1ccc(Cl)cc1Cl)c1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC8 Q9BY41 7/20 0.54
EPHX1 P07099 1/20 0.53
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
CYP3A4 P08684 2/20 0.50
CYP2C9 P11712 2/20 0.50
CYP1A2 P05177 1/20 0.50
CYP2D6 P10635 1/20 0.50
CYP2C19 P33261 1/20 0.50
SLC6A4 P31645 1/20 0.49
HDAC3 O15379 1/20 0.48
HDAC1 Q13547 1/20 0.48
HDAC2 Q92769 1/20 0.48
HDAC6 Q9UBN7 1/20 0.48
CHRNB2 P17787 1/20 0.47
CHRNA4 P43681 1/20 0.47
PPARA Q07869 2/20 0.46
TBXA2R P21731 1/20 0.45
PTGFR P43088 1/20 0.45
PTGER3 P43115 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11857052 0.84 HDAC8 (0.55) HDAC8EPHX1MEN1KMT2ACYP3A4
SCHEMBL22394880 0.83 PPARG (0.51) EPHX1MEN1KMT2ACYP2C9CYP1A2
SCHEMBL11851540 0.83 HDAC8 (0.44) HDAC8EPHX1MEN1KMT2ACYP3A4
SCHEMBL15553764 0.80 HDAC8 (0.54) HDAC8EPHX1MEN1KMT2ACYP3A4
SCHEMBL15552015 0.80 HDAC8 (0.54) HDAC8EPHX1MEN1KMT2ACYP3A4
SCHEMBL11458388 0.80 IDO1 (0.49) HDAC8EPHX1CYP3A4CYP2C9CYP1A2
Hydrochloric Acid SCHEMBL15553724 0.79 HDAC8 (0.56) HDAC8EPHX1MEN1KMT2ACYP3A4
Hydrochloric Acid SCHEMBL15555247 0.79 HDAC8 (0.56) HDAC8EPHX1MEN1KMT2ACYP3A4
Hydrochloric Acid SCHEMBL15553823 0.79 HDAC8 (0.56) HDAC8EPHX1MEN1KMT2ACYP3A4
SCHEMBL10972042 0.79 CHRNB2 (0.54) HDAC8EPHX1MEN1KMT2ACYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7105509-B2 Benzodiazepine derivatives as APP modulators MERCK SHARP & DOHME LIMITED (GB) 2006-09-12 US disclosed
US-20040082572-A1 Benzodiazepine derivatives as app modulators MERCK SHARPE & DOHME LIMITED (GB) 2004-04-29 US disclosed
EP-1294702-A1 BENZODIAZEPINE DERIVATIVES AS APP MODULATORS MERCK SHARP & DOHME LTD. (GB) 2003-03-26 EP disclosed
WO-2001090084-A1 BENZODIAZEPINE DERIVATIVES AS APP MODULATORS MERCK SHARP & DOHME LIMITED (GB) 2001-11-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040082572-A1 Benzodiazepine derivatives as app modulators BACE1, PSEN1, APP HDAC8 2140/4885EPHX1 818/4885MEN1 3871/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.